Skip to main content
Premium Trial:

Request an Annual Quote

Duke University s Brain Cancer Genomics Lab Taps Agencourt to Help Research

NEW YORK, March 25 - Agencourt Bioscience on Monday said that the Duke University Medical Center has picked its Solid Phase Reversible Immobilization technology to help its cancer research.

The deal, funded by the National Cancer Institute's Cancer Genome Anatomy Project, will give researchers at Duke's Brain Cancer Genomics Laboratory access to Agencourt's SPRI technology to help them determine the molecular anatomy of normal, pre-cancer, and cancer cells. Terms also call for Agencourt to sequence Duke's SAGE libraries.

Financial details of the deal were not disclosed, though both groups said that all resources generated by the project will be publicly available.


"Mapping, evaluating, and sequencing the genes of cells at various stages of cancer growth will eventually lead to improved detection, diagnosis and treatment for cancer patients," Agencourt said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.